No photo of David P Richman

View Scopus Profile

David P Richman, MD

Professor

  • 3405 Citations
  • 31 h-Index
1969 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David P Richman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Myasthenia Gravis Medicine & Life Sciences
Cholinergic Receptors Medicine & Life Sciences
Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Torpedo Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Nicotinic Receptors Medicine & Life Sciences
Bungarotoxins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1979 2013

Antigen-specific treatment of myasthenia gravis: Chimeric autoantibody receptor T cells targeting autoimmune B cells

Richman, D. P.

Project: Research project

Development of Animal Models of Anti-MuSK Myasthenia

Richman, D. P.

National Institutes of Health

9/30/10 → 8/31/13

Project: Research project

Phosphotransferases
Animal Models
Muscles
Neuromuscular Junction
Muscle Weakness

IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS

Richman, D. P.

National Institutes of Health

5/1/97 → 4/30/98

Project: Research project

Myasthenia Gravis
Lambert-Eaton Myasthenic Syndrome
Posters
Fees and Charges
Clinical Pharmacology

STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES

Fairclough, R. H., Richman, D. P., Nelson, D., Martinez-Carrion, M. & Kezdy, F.

National Institutes of Health

1/1/87 → 9/30/92

Project: Research project

Cholinergic Receptors
Epitopes
acetylcholine
Blocking Antibodies
Monoclonal Antibodies

PATHOGENIC MECHANISMS IN MYASTHENIA

Richman, D. P.

National Institutes of Health

7/1/84 → 6/30/97

Project: Research project

Myasthenia Gravis
Monoclonal Antibodies
Cholinergic Receptors
Antibodies
Autoimmune Diseases

Research Output 1969 2019

1 Citation (Scopus)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma

Lara, M. S., Afify, A. M., Ellis, M. P., Phan, C., Richman, D. P. & Riess, J., Jan 1 2019, In : Clinical lung cancer.

Research output: Contribution to journal › Article

Thymoma
Myasthenia Gravis
Immunotherapy

Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia

on behalf of the DAPPER Study Team, Jan 1 2019, In : Muscle and Nerve. 60, 3, p. 292-298 7 p.

Research output: Contribution to journal › Article

Lower Extremity
Lambert-Eaton Myasthenic Syndrome
Research Personnel
Physicians
3,4-diaminopyridine
11 Citations (Scopus)

3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia

Sanders, D. B., Juel, V. C., Harati, Y., Smith, A. G., Peltier, A. C., Marburger, T., Lou, J. S., Pascuzzi, R. M., Richman, D. P., Xie, T., Demmel, V., Jacobus, L. R., Aleš, K. L. & Jacobus, D. P., Jan 1 2018, (Accepted/In press) In : Muscle and Nerve.

Research output: Contribution to journal › Article

Placebos
Maintenance
3,4-diaminopyridine
Pharmaceutical Preparations
Therapeutics
5 Citations (Scopus)

Developing treatment guidelines for myasthenia gravis

The MGFA Task Force On Mg Treatment Guidance, Jan 1 2018, In : Annals of the New York Academy of Sciences. 1412, 1, p. 95-101 7 p.

Research output: Contribution to journal › Review article

Intravenous Immunoglobulins
Myasthenia Gravis
Immunosuppressive Agents
Protein-Tyrosine Kinases
Muscle
1 Citation (Scopus)

Reply

Sanders, D. B., Harati, Y., Juel, V. C., Lou, J. S., Marburger, T., Pascuzzi, R. M., Peltier, A. C., Richman, D. P. & Smith, A. G., May 1 2018, In : Muscle and Nerve. 57, 5, p. E130-E131

Research output: Contribution to journal › Letter